Role of vemurafenib in melanoma treatment
Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK
Role of vemurafenib in melanoma treatment ( Dr Paul Nathan - Mount Vernon Cancer Centre - Northwood, UK )
24 Jun 2011
Combining oral targeted therapies shows early anti-tumour activity for advanced ...
Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA
Combining oral targeted therapies shows early anti-tumour activity for advanced melanoma ( Dr Jeffrey Infante - Sarah Cannon Research Institute, Nashville, USA )
20 Jun 2011
Cancer prevention through education
Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy
Cancer prevention through education ( Prof Angelo Paradiso - Istituto Tumori ‘Giovanni Paolo II’, Bari, Italy )
17 Jun 2011
Highlights from 2011 and ASCO’s future
Prof George Sledge - Indiana University, USA
Highlights from 2011 and ASCO’s future ( Prof George Sledge - Indiana University, USA )
17 Jun 2011
Ipilimumab improves survival in metastatic melanoma
Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA
Ipilimumab improves survival in metastatic melanoma ( Prof Jedd Wolchok - Memorial Sloan-Kettering Cancer Center, New York, USA )
17 Jun 2011
New melanoma drug gives 63 percent reduction in risk of death compared to dacarb...
Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center
New melanoma drug gives 63 percent reduction in risk of death compared to dacarbazine ( Dr Paul Chapman, Memorial Sloan-Kettering Cancer Center )
17 Jun 2011
ASCO 2011 highlights
Prof Gordon McVie – ecancer Managing Editor
ASCO 2011 highlights ( Prof Gordon McVie – ecancer Managing Editor )
16 Jun 2011
The future of medicine: personalised
Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany
The future of medicine: personalised ( Prof Hans Lehrach - Max Planck Institute for Molecular Genetics, Berlin, Germany )
2 Jun 2011
Reducing global cancer mortality
Prof Peter Boyle - International Prevention Research Institute, Lyon, France
Reducing global cancer mortality ( Prof Peter Boyle - International Prevention Research Institute, Lyon, France )
2 Jun 2011
The Cancer Genome Atlas (TCGA)
Dr Paul Spellman - National Cancer Institute, Bethesda, USA
The Cancer Genome Atlas (TCGA) ( Dr Paul Spellman - National Cancer Institute, Bethesda, USA )
21 Apr 2011
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity
Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA
Combination therapy targeting MEK and PI3K pathways shows anti-tumour activity ( Dr Johanna Bendell - Sarah Cannon Research Institute, Nashville, USA )
20 Apr 2011
Ethical considerations surrounding cancer in the elderly and the pros and cons o...
Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen V...
Ethical considerations surrounding cancer in the elderly and the pros and cons of web-based resources ( Ian Banks (European Men's Health Forum), Jan Geissler (Leukamie-Online), Ellen Verschuur (Europa Donna) )
17 Mar 2011